- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03264222
Safety of a New Security Device in Patients With Implanted Cardiac Electronic Devices
July 31, 2021 updated by: Deutsches Herzzentrum Muenchen
Patients with implantable cardiac electronic devices will be exposed to a new safety device and evaluated for potential electromagnetic interference.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Patients with implanted pacemakers or defibrillators will undergo a screening procedure with an innovative security device.
Evaluation will be made with respect to the occurrence of interference.
Study Type
Interventional
Enrollment (Actual)
379
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Bavaria
-
Munich, Bavaria, Germany, 80636
- Deutsches Herzzentrum München
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- implantable pacemaker or defibrillator in situ
Exclusion Criteria:
- malfunction of implantable pacemaker or defibrillator
- low battery voltage of implanted cardiac electronic device
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
OTHER: Exposition to safety screening
One armed study with exposition to a new safety device (model QPS100) using radiofrequency technology
|
Screening procedure with security device (model QPS 100)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Electromagnetic interference
Time Frame: 10 minutes
|
Occurrence of electromagnetic interference
|
10 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
May 1, 2017
Primary Completion (ACTUAL)
July 12, 2018
Study Completion (ACTUAL)
October 31, 2018
Study Registration Dates
First Submitted
June 26, 2017
First Submitted That Met QC Criteria
August 24, 2017
First Posted (ACTUAL)
August 29, 2017
Study Record Updates
Last Update Posted (ACTUAL)
August 6, 2021
Last Update Submitted That Met QC Criteria
July 31, 2021
Last Verified
July 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- GER-EP-017
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Electromagnetic Interference
-
Deutsches Herzzentrum MuenchenCompletedElectromagnetic InterferenceGermany, Greece
-
Edward-Elmhurst Health SystemCompletedElectromagnetic InterferenceUnited States
-
University Hospital, GenevaCompletedElectromagnetic InterferenceSwitzerland
-
Maisonneuve-Rosemont HospitalCompletedElectromagnetic Interference
-
Deutsches Herzzentrum MuenchenCompletedElectromagnetic InterferenceGermany
-
University Hospital, GenevaUnknownElectromagnetic InterferenceSwitzerland
-
Chiang Mai UniversityThailand Research FundUnknownElectromagnetic Interference in Cardiovascular Implantable Electronic Device
-
University of Mogi das CruzesCompleted
-
University of Mogi das CruzesCompletedBalancing InterferenceBrazil
-
Clinique BizetCompletedElectromagnetic Emissions and Emotional Disorder | Electromagnetic Emissions and Medication SavingsFrance
Clinical Trials on Security screening procedure
-
University of California, San DiegoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Rady...Recruiting
-
Nordsjaellands HospitalActive, not recruitingInflammatory Bowel Diseases
-
University of ChicagoCompleted
-
University College London HospitalsCompleted
-
FH Joanneum Gesellschaft mbHRecruitingCognitive Change | AgingAustria
-
University of SouthamptonUnknownUnipolar DepressionUnited Kingdom
-
Centre Hospitalier Universitaire, AmiensUnknownTreatment of Suicidal Recidivism in Adolescents PopulationFrance
-
Gloucestershire Hospitals NHS Foundation TrustUnknownEsophageal Cancer | Precancerous ConditionUnited Kingdom
-
Bukret Plastic SurgeryCompletedBody Dysmorphic DisorderArgentina
-
Ohio State University Comprehensive Cancer CenterCompletedCervical Carcinoma | Human Papillomavirus InfectionUnited States